[1]
Aloufi, L.K., Almaysari, R.K., Aljehani, A.T., Mohammed D., A.D. and Alnefaie, Z.M. 2025. Pharmacological, behavioral, and sociocultural dimensions of GLP-1 and dual incretin therapies in Saudi Arabia: clinical evidence, misuse patterns, and policy priorities. International Journal of Basic & Clinical Pharmacology. 15, 1 (Dec. 2025), 158–165. DOI:https://doi.org/10.18203/2319-2003.ijbcp20254166.